News | October 01, 2009

GEMS Air Wireless ECG Continuously Monitors Heart Rhythm Abnormalities

October 2, 2009 – CardioComm Solutions Inc. said yesterday it added the company’s wireless ECG management system to its suite of GEMS (Global ECG Management System) products. GEMS Air builds on the GEMS platform and incorporates software capable of continuously receiving and managing recordings of the heart’s activity over a wireless network instead of a land-line telephone network.

The company said the benefit of wireless monitoring to the cardiologist or cardiac service is that it provides a better diagnostic yield and improved patient care management. The continuous stream of monitoring information reflects a more complete picture of a patient’s cardiac activity hour by hour, day to day, with abnormalities being detected earlier than, for example, with Holter monitoring.

GEMS Air permits continuous wireless transmission without the patient needing to call in information. Abnormalities are automatically recognized and sent to the medical team. Although some large call centers use a similar process with their own dedicated and exclusive devices, GEMS Air is the first time that there is an opportunity for patients and physicians to have a choice in selecting from a variety of wireless devices for their own direct use.

The GEMS Air also provides an open architecture for communication with devices from any heart ECG loop event recorder manufacturer and offers extensive and detailed standard and custom reports. The reports are posted to secure Web sites in real time. The system is fully-scalable and can be used by small clinics or large hospitals. The AutoAttendant module is a computer-automated answering of event recorder transmissions that can be added to help improving efficiency and reducing staffing. The system has HL7 compatibility for seamless EMR incorporation.

The GEMS Air systems are FDA and Health Canada approved.

For more information: www.cardiocommsolutions.com

Related Content

FDA Clears AliveCor's KardiaMobile 6L as First Six-Lead Personal ECG Device
Technology | ECG | May 13, 2019
AliveCor announced its third U.S. Food and Drug Administration (FDA) clearance in three months, making KardiaMobile 6L...
One innovation in ECG is its use in the customer wearable market, which will tie more closely into the clinical world either with using the data to triage patients and/or patients seeking medical attention prior to acute symptoms appearing.

One innovation in ECG is its use in the customer wearable market, which will tie more closely into the clinical world either with using the data to triage patients and/or patients seeking medical attention prior to acute symptoms appearing.

Feature | ECG | May 03, 2019 | Sanket Solanki
Technology has made its way into the healthcare sector and brought a drastic transformation.
Videos | ECG | March 05, 2019
This is a quick demo of the Schiller Cardiovit FT-1 electrocardiograph (ECG) system displayed at the ...
EKG With Artificial Intelligence Reliably Detects Heart Failure Precursor
News | ECG | January 08, 2019
January 8, 2019 — A Mayo Clinic study finds that applying...
Use of traditional Holter monitor leads can be an issue for patient compliance and comfort. The newer generation ambulatory cardiac monitors use an adhesive patch that sticks directly on the patient's chest and allows them to shower and go about daily activities without a belt mounted monitor or leads getting in the way. This is especially important for longer term monitoring of seven days or longer.

Use of traditional Holter monitor leads can be an issue for patient compliance and comfort. The newer generation ambulatory cardiac monitors use a small, adhesive patch that sticks directly on the patient's chest and allows them to shower and go about daily activities without a belt mounted monitor or leads getting in the way. This is especially important for longer term monitoring of seven days or longer. 

Feature | ECG | September 27, 2018
Advances in the technology of wearable cardiac monitors are improving both the experience of the patient and the effe
HeartSciences MyoVista ECG Device Shows Promise in Detecting Abnormal Cardiac Function
News | ECG | April 27, 2018
HeartSciences announced the results of a clinical study of its electrocardiography device that applies continuous...
ECG Study of NBA Players Shows Need for Sport-Specific Normative Data and Guidelines
News | ECG | December 08, 2017
Cardiologists at NewYork-Presbyterian/Columbia University Irving Medical Center compared electrocardiographic findings...
HeartSciences Announces CE Mark and European Launch of MyoVista High Sensitivity ECG

Just as a Doppler radar color image shows the energy of a storm, MyoVista provides physicians a detailed visual image of the energy distribution during the cardiac cycle.

News | ECG | August 22, 2017
HeartSciences announced the European launch of the MyoVista high sensitivity electrocardiograph (hsECG) Testing Device...
AUM Cardiovascular Receives FDA Approval for CADence ECG Device
Technology | ECG | August 08, 2017
AUM Cardiovascular announced it has received clearance from the U.S. Food and Drug Administration (FDA) for CADence, a...
More Than 20 Percent of Low-Risk Patients Receive Annual ECG
News | ECG | July 20, 2017
July 20, 2017 — More than one in five Ontario patients receive an ...
Overlay Init